- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00546221
Promoting Wellbeing for Women With Depression: A Pragmatic Randomised Controlled Trial (RCT) of an Exercise Programme
March 2, 2011 updated by: University of Nottingham
Pragmatic Randomised Controlled Trial of a Preferred Intensity Exercise Programme to Improve Physiological and Associated Psychological, Social, and Wellbeing Outcomes of Women Living With Depression
The investigators want to find out if their specially designed exercise programme will be more successful at helping women with depression to feel better than a basic programme will, by measuring the effect the programme has on mood, physical health, and social wellbeing.
Their specially designed exercise programme will involve physical exertion at the participants' chosen level of intensity (how hard the body has to work during exercise), and will include motivational support.
By contrast, the basic exercise programme will be at an intensity recommended by national guidelines, of the type that may be prescribed by a general practitioner (GP), and will include no extra motivational support.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
43
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nottinghamshire
-
Nottingham, Nottinghamshire, United Kingdom
- Nottingham City Primary Care Trust
-
Nottingham, Nottinghamshire, United Kingdom
- Nottinghamshire County Teaching Primary Care Trust
-
Nottingham, Nottinghamshire, United Kingdom
- Nottinghamshire Healthcare Nhs Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Living with depression
- Aged 18 (age at first session of programme)
- Female
- Living in the community
- Resident within Nottinghamshire (personal address has Nottinghamshire postcode)
Exclusion Criteria:
- Women who, at the time of the study, are unable to participate on account of any injury or physical health problem that precludes their participation
- Women participating in research that may undermine the scientific basis of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Psychosocial support
Comprising 22 participants engaging in the experimental exercise programme, exercising with psychosocial support.
|
The experimental arm will experience 12 sessions of intervention, at a rate of three sessions a week for four weeks, exercising in groups of ten women.
Each session will comprise: fifteen minutes of psychosocial and motivational support, run by a qualified rehabilitation psychologist and overseen by a qualified health psychologist; a half hour preferred intensity exercise session run by a qualified sports physiotherapist.
Participants preferred intensity (chosen exertion level) will be established using the Borg RPE scale (Borg G 1998).
|
|
Active Comparator: Prescribed exercise
Comprising 21 participants engaging in a programme of typical prescribed exercise.
|
This group will experience 12 sessions of intervention, at a rate of three sessions a week for four weeks, exercising in groups of ten women.
Each session will be an half hour exercise session, at a typically (GP) prescribed level, designed in accordance with national guidelines and run by a qualified sports physiotherapist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The primary outcome measure is score on the BDI-II (Beck Depression Inventory version 2).
Time Frame: At the plenary session of the programmes.
|
At the plenary session of the programmes.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Resting heart rate.
Time Frame: At the plenary session of the programmes.
|
At the plenary session of the programmes.
|
|
GHQ12.
Time Frame: At the plenary session of the programmes.
|
At the plenary session of the programmes.
|
|
The SF-12vII.
Time Frame: At the plenary session of the programmes.
|
At the plenary session of the programmes.
|
|
The Rosenberg self-esteem scale.
Time Frame: At the plenary session of the programmes.
|
At the plenary session of the programmes.
|
|
Quality of life in depression scale.
Time Frame: At the plenary session of the programmes.
|
At the plenary session of the programmes.
|
|
The multidimensional scale of perceived social support.
Time Frame: At the plenary session of the programmes.
|
At the plenary session of the programmes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Patrick Callaghan, RN BSc MSc PhD CPsychol, University of Nottingham
- Principal Investigator: Elizabeth B Khalil, BSc MSc PhD (Cant.), University of Nottingham
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2007
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
October 17, 2007
First Submitted That Met QC Criteria
October 17, 2007
First Posted (Estimate)
October 18, 2007
Study Record Updates
Last Update Posted (Estimate)
March 3, 2011
Last Update Submitted That Met QC Criteria
March 2, 2011
Last Verified
March 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07105
- Funder's ID: 293/350
- Ethics ref ID: 07/H0401/110
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Psychosocial support exercise programme
-
Hannover Medical SchoolRoche Pharma AGUnknown
-
Hannover Medical SchoolRoche Pharma AGUnknownHeart Transplantation | Exercise Capacity
-
Royal Holloway UniversitySentebale; African Comprehensive HIV/AIDS PartnershipCompleted
-
Kastamonu UniversityCompletedChildren | Parent Child Relationships | Psychosocial DevelopmentTurkey
-
Universidad de La FronteraUniversity of ChileRecruitingHeart Failure NYHA Class II | Heart Failure NYHA Class IIIChile
-
Hospices Civils de LyonUnknownAlzheimer DiseaseFrance
-
Sakarya UniversityThe Scientific and Technological Research Council of TurkeyRecruitingCongenital Abnormalities | Fetal Diseases | Pregnant Women | Mental Health | Psychosocial Support SystemsTurkey
-
Duke UniversityGlioblastoma FoundationCompleted
-
Wake Forest University Health SciencesCompletedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of OsloCompleted